Literature DB >> 3045740

Autoradiographic determination of regional cerebral blood flow during hypoglycemia in newborn dogs.

M Anwar1, R C Vannucci.   

Abstract

To ascertain the regional cerebral blood flow (CBF) responses to hypoglycemia, nine newborn dogs were treated with insulin to blood glucose concentrations ranging from 1 to 35 mg/dl (mean 22 mg/dl). Systemic physiologic monitoring revealed no differences in mean arterial blood pressure, heart rate, paO2, paCO2, pHa, or blood lactate in the hypoglycemis animals and five normoglycemic controls. Significant increases in CBF occurred in 17 of 20 analyzed structures of brain in the hypoglycemic puppies, ranging from 158 to 446% of the normoglyycemic values. The percent increases in CBF were greatest in brainstem structures compared to other major regions of brain. A positive correlation existed between mean arterial blood pressure and cerebral cortical blood flow, suggesting a loss of CBF autoregulation during hypoglycemia. The pathophysiologic mechanism for the elevations in regional CBF might relate to stimulation of beta-adrenergic receptors in brain, as has been shown in adults.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045740     DOI: 10.1203/00006450-198807000-00011

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

Review 1.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  Contribution of the blood glucose level in perinatal asphyxia.

Authors:  Pallab Basu; Sabbasachi Som; Nabendu Choudhuri; Harendranath Das
Journal:  Eur J Pediatr       Date:  2008-10-09       Impact factor: 3.183

3.  Patterns of metabolic adaptation for preterm and term infants in the first neonatal week.

Authors:  J M Hawdon; M P Ward Platt; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.